JEIL PHARMACEUTICAL CO., LTD.

ACTIVE

Jeil Pharma Holdings Bldg., Seoul, 首尔特别市, South Koreawww.jeilpharm.co.krPublic999 employees

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

58.3%

Phase 3

16.7%

Phase 2

8.3%

Not Applicable

5.6%

Phase 4

2.8%

Trial Status Distribution

Completed

80.6%

Not yet recruiting

2.8%

Recruiting

5.6%

Unknown

11.1%

Clinical Trials

Trials sponsored by this organization (36)

JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD

Not yet recruiting

observational

Aug 20257,150 participants

Observationa Study is a Prospective and Multi-institutional Observational Study.

Completed

observational

Nov 20245,536 participants

To Evaluate the Safety, Pharmacokinetic Characteristics and the Effect of Food After Administration of JLP-2004

Phase 1

Recruiting

interventional

Apr 202436 participants

Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients

Phase 2

Completed

interventional

Nov 2023161 participants

To Evaluate the Safety and Pharmacokinetic Characteristics After Multiple Administration of JC-013 and JLP-2004

Phase 1

Completed

interventional

Oct 202360 participants

To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP-2008

Phase 1

Completed

interventional

May 202248 participants

To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

Phase 3

Unknown

interventional

Apr 2022245 participants

To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901

Phase 1

Completed

interventional

Feb 202248 participants

Page 1 of 5

Approvals

Approvals by Agency

PHILIPPINES

Philippines FDA

Approvals

Recent Approvals

News

No news articles found

Back to Organizations